Abstract-Extensive research on the role of ADP in platelet activation led to the design of new anti-thrombotic drugs, such as clopidogrel (Plavix; sanofi-aventis); however, very little is known about the ADP-preferring nucleotide receptors (P2Y 1 , P2Y 12 , and P2Y 13 ) in endothelium. Here, we show that ADP stimulates migration of cultured human umbilical vein endothelial cells (HUVECs) in both Boyden chamber and in vitro wound repair assays. This promigratory effect was mimicked by 2-MeSADP, but not by AMP, and was inhibited by MRS2179 (P2Y 1 receptor antagonist) but not by AR-C69931MX (P2Y 12/13 receptor antagonist). RT-PCR revealed abundant P2Y 1 , barely detectable P2Y 12 , and absent P2Y 13 receptor message in these cells. In addition, both ADP and 2-MeSADP, but not AMP, activated the mitogen-activated protein kinase pathways as evidenced by increased phosphorylation of extracellular signal-regulated kinase (ERK)1/2, c-Jun N-terminal kinase (JNK), and p38 kinase. ADP also stimulated phosphorylation of p90RSK, a downstream substrate of phosphorylated ERK1/2, and induced phosphorylation of such transcription factors downstream of the JNK and p38 pathways as c-Jun and activating transcription factor-2. These signaling events were inhibited by MRS2179 but not by AR-C69931MX. Furthermore, blockade of the ERK or JNK pathways by U0126 and SP600125, respectively, abolished ADP-and 2-MeSADP-stimulated HUVEC migration. However, inhibition of the p38 pathway by SB203580 partially suppressed ADP-and 2-MeSADP-induced HUVEC migration. We conclude that ADP promotes human endothelial cell migration by activating P2Y 1 receptor-mediated MAPK pathways, possibly contributing to reendothelialization and angiogenesis after vascular injury. V ascular endothelial cell migration and proliferation are vital in many physiological and pathological processes, including organ development, angiogenesis, and healing of the injured endothelium. 1,2 Numerous factors produced within the vascular wall or from the circulating blood can stimulate migration and/or proliferation of endothelial cells through their cognate receptors, which are either receptor tyrosine kinases, such as vascular endothelial growth factor (VEGF), or G protein-coupled receptors, such as thrombin. 2,3 In addition to these well-established factors, extracellular nucleotides are relatively newly defined vasoactive substances in the vasculature. 4 -6 ATP and UTP stimulate vascular smooth muscle constriction and proliferation 5,6 ; however, in intact arteries, nucleotides usually cause endotheliumdependent relaxation, 5 suggesting that endothelium has 1 or more functional nucleotide receptors. Indeed, among the 8 cloned P2Y nucleotide receptors (P2Y 1,2,4,6,11,12,13,14 ), 5 a previous study in human vascular endothelial cells showed significant level of P2Y 1 , P2Y 2 , and P2Y 11 receptor mRNAs. The expression levels of the newly cloned P2Y 12 , 13 , 14 receptors were not investigated. 7 It also has been shown that stimulation of the P2Y 2 receptor by ATP or UTP in cultur...